We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 176 to 200
-
Media releasesPrecision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products
-
Media releasesOn 28 June 2022 the TGA granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, COMIRNATY.
-
Media releasesThe TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.
-
Media releasesThe TGA has commenced court proceedings in the Federal Court of Australia against Prefixx Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.
-
Media releasesThe transition period from the 2018 to the 2021 Advertising Code ends 30 June 2022.
-
Media releasesThe TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.
-
Media releasesThe TGA has issued four infringement notices totalling $10,664 to an individual for alleged unlawful importation of COVID-19 rapid antigen tests (RATs).
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a NSW based individual for the alleged unlawful advertising of a medicine that was not included in the Australian Register of Therapeutic Goods.
-
Media releasesThe TGA has issued ten infringement notices totalling $133,200 to Philips Electronics Australia Ltd.
-
Media releasesThe TGA has issued 15 infringement notices totalling $39,960 to a New South Wales based individual for alleged unlawful importation of the prescription-only medicines ivermectin and doxycycline.
-
Media releasesThe TGA has cancelled the listed complementary medicine FatBlaster Max (AUST L 348163) from the Australian Register of Therapeutic Goods (ARTG) for alleged breaches of the Therapeutic Goods Act 1989.
-
Media releasesTMF Cosmeceuticals Pty Ltd fined $26,640 for alleged unlawful importation of ivermectin
-
Media releasesThe TGA has issued three infringement notices totalling $39,960 to New South Wales based company Khazanah Nasional Pty Ltd for alleged unlawful advertising of disposable liquid nicotine vaping products.
-
Media releasesAussiewhip Pty Ltd fined $39,960 for alleged unlawful advertising of disposable nicotine vaping products
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a Sydney based individual for alleged unlawful importation of unregistered anaesthetic products.
-
Media releasesThe TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
-
Media releasesThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
-
Media releasesFuturePro was convicted and released on recognisance, its directior was convicted and fined $25,000.
-
Media releasesIndividual fined $2,664 for unlawful importation of nicotine vaping pods
-
Media releasesOn 7 April 2022, the TGA announced receipt of an application from GlaxoSmithKline (GSK) Australia Pty Ltd for a higher (1000 mg) dose of its COVID-19 treatment, XEVUDY (sotrovimab).
-
Media releasesThe TGA has granted provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir).
-
Media releasesOn 27 April 2022 the TGA granted a provisional determination to Moderna Australia Pty Ltd in relation to its bivalent COVID-19 vaccine, elasomeran/elasomeran 0-omicron (SPIKEVAX Bivalent Zero/Omicron).
-
Media releasesCheckMe Pty Ltd fined $13,320 for unlawful import of COVID-19 test kits
-
Media releasesG1 Resources Pty Ltd fined for alleged unlawful importation and advertising of unapproved rapid antigen tests
-
Media releasesCat Media Pty Ltd fined $39,960 for allegedly advertising unregistered Fatblaster weight-loss products